Business Context and Reporting Period
This Form 6-K filing by Compugen Ltd. covers the period ending February 12, 2026. The report serves to disclose a corporate governance update regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is non-financial in nature and focuses solely on a personnel appointment.
Material Changes
The material change disclosed is the appointment of Michele Holcomb, Ph.D., as a new independent director. Her appointment became effective on February 11, 2026.
Outlook and Management Commentary
- Term of Office: Dr. Holcomb will hold office until immediately following the Company's 2026 annual general meeting of shareholders, until her successor is elected, or until her office is vacated earlier in accordance with the Companies Law and the Articles.
- Reference: The press release detailing this appointment is furnished as Exhibit 99.1 and incorporated by reference into the Company's Registration Statement on Form F-3.
Key Facts for Investor Verification
- Verify the full text of the press release (Exhibit 99.1) for Dr. Holcomb's specific qualifications and background.
- Confirm the date of the upcoming 2026 annual general meeting to determine the exact end date of her initial term.
- Note that this filing contains no financial performance data or operational updates.